Facts and figures 2010

PHARMAQ's position in the global market place for vaccines and therapeutic products for the salmonid farming industry has never been stronger than at year end 2010. Through the introduction of the company's ISA vaccines in Chile and a further increase in vaccine sales to the Norwegian fish farming industry, 50 percent of the salmonids on a global scale were vaccinated with a PHARMAQ vaccine in 2010.

PHARMAQ statistics for Norway April 2012

No surprises in April sales of vaccines

The sales of vaccines to Atlantic salmon in April ended nearly 5 million doses compared to 3.8 million doses in April 2011. The vaccination season for the S1 2012 generation is considered throughout May. In May 2011 9.2 million vaccine doses were ordered for salmon. Per May 15 we believe this month's sales will be reduced compared to May last year. In total our estimate so far indicates sales of 159 million vaccine doses to the S1s-2012 compared to 156 million doses to the S1s- 2011 generation at the same point in time.

April sales of PD-vaccine ended at 1.5 million doses compared to 2.0 million in April 2011.

Looking at vaccine sales to rainbow trout, we find this segment at a very stable level. Ever since autumn 2010 the variation in sales measured as twelve months rolling sales, has varied from 17 to 20 million doses of oil based vaccines. Per April 2012 the twelve month's trend is at 18 million doses.

Sales for farmed cod in April were 200.000 vaccine doses compared to 400.000 doses the same month last year. Over the last six months vaccine sales is seen on a steady level of approximately 3 million doses per year.